Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-09-13A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
-
CLINICAL_TRIALS study record update · 2023-09-13ARTiBIOME: Effect of HIV and ART on Gut Microbiome
-
CLINICAL_TRIALS study record update · 2023-09-13Multi-center Study to Evaluate Virological Efficacy, Safety Tolerability, Drug Exposure and Patients' Reported Outcomes Over 48 Weeks Following Randomization to 2-drug Therapy With DTG/3TC FDC or Continuing Current Antiretroviral Tenofovir (TAF or TDF)-Containing Regimen (T-CR) in HIV-1 Infected Virologically Suppressed
-
CLINICAL_TRIALS study record update · 2023-09-13A Randomized Trial of HAART in Acute/Early HIV Infection
-
CLINICAL_TRIALS study record update · 2023-09-07A Phase I, Open-Label Study of the Safety and Ability of Broadly Neutralizing Antibodies 3BNC117-LS and 10-1074-LS in Combination to Durably Prevent Viral Relapse During a Monitored Analytical Treatment Interruption
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-09-06Prevalence of Frailty in Individuals With HIV Infection and Age Older Than 60 Years, Factors Associated and 6-month Effectiveness of a Multifactorial Intervention: HIDRA360
-
CLINICAL_TRIALS study record update · 2023-08-31Evaluating the Impact of HIV-1 Recent Infection Testing on Incremental HIV Testing Yield and Adverse Events Linked to Return of Recent Infection Testing Results in Rwanda
-
CLINICAL_TRIALS study record update · 2023-08-30Incidence and Mortality of Hepatocellular Carcinoma in HIV-infected Individuals in an Asian Population
-
CLINICAL_TRIALS study record update · 2023-08-30Frailty in Older HIV-infected Individuals in Hong Kong: Risk Factors and Association With Quality of Life and Mortality
-
CLINICAL_TRIALS study record update · 2023-08-25A Phase IV, Open-label, Multicenter and Single-arm on the Immunogenicity of Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017
-
CLINICAL_TRIALS study record update · 2023-08-25A 14 Day Randomized, Double-blind, Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation
-
CLINICAL_TRIALS study record update · 2023-08-23A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK3739937 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2023-08-21Open-Label, Single-Sequence Study to Evaluate the Effects of Darunavir/Ritonavir and/or Etravirine on the Pharmacokinetics of GSK3640254 and the Effects of GSK3640254 on the Pharmacokinetics of Darunavir/Ritonavir and/or Etravirine in Heathy Adults
-
CLINICAL_TRIALS study record update · 2023-08-21Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
-
CLINICAL_TRIALS study record update · 2023-08-21Adherence and Pharmacokinetics Measures in People Living With HIV Receiving Tenofovir Disoproxil Fumarate-based Regimens in Indonesia
-
CLINICAL_TRIALS study record update · 2023-08-16A Practical Adherence Toolkit for Managing Nonadherence to HIV Medications in Indonesia: Protocol for a Usability Study and Cluster Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-08-14An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment for 48 Weeks in Participants Who Have Completed 96 Weeks of Elvucitabine Therapy in Protocol ACH443-015 or 48 Weeks of Therapy in Protocol ACH443-018
-
CLINICAL_TRIALS study record update · 2023-08-04Phase 3B, Randomized, Open-Label, Safety, and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs
-
CLINICAL_TRIALS study record update · 2023-07-25Vitamin E for NASH Treatment in HIV Infected Individuals
-
CLINICAL_TRIALS study record update · 2023-07-20Adherence to Antiretroviral Therapy in HIV Infected Individuals in Assiut Governorate, Egypt
-
CLINICAL_TRIALS study record update · 2023-07-11Investigation of the Effectiveness of Biopsychosocial Exercise Therapy Approach With Telerehabilitation in Patients Living With HIV
-
CLINICAL_TRIALS study record update · 2023-07-03CHAMPS: Choices For Adolescent Prevention Methods For South Africa. Pilot Study B: 'PlusPills'
-
CLINICAL_TRIALS study record update · 2023-07-03Connecting Youth and Young Adults to Optimize ART Adherence: Testing the Efficacy of the Youth Thrive Intervention
-
CLINICAL_TRIALS study record update · 2023-06-28Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma
-
CLINICAL_TRIALS study record update · 2023-06-28Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users